Sirona Biochem Corp. (SBM.V)

0.3050 +0.0050 (+1.67%) At close: 3:59PM EDT

Sirona Biochem Corp.

595 Burrard Street
Vancouver, BC V7X 1L4
Canada
604 641 4466
http://www.sironabiochem.com

Sector(s): Healthcare
Industry: Biotechnology
Full Time Employees: 

Key Executives

Name	Title	Pay	Exercised	Year Born
Dr. Howard J. Verrico Ph.D., M.D.	Founder, Chairman, CEO & Sec.	245.2k	N/A	1961
Mr. Christopher D. Hopton	CFO & Director	212.6k	N/A	1966
Dr. Géraldine Deliencourt-Godefroy	Chief Scientific Officer & Director	252.39k	N/A	N/A
Ms. Michelle Seltenrich MBA	VP of Operations	N/A	N/A	N/A
Dr. Brett A. Premack Ph.D.	Scientific Consultant	N/A	N/A	N/A

Amounts are as of December 31, 2019 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in CAD.

Description

Sirona Biochem Corp., a cosmetic ingredient and drug discovery company, develops and sells cosmetic and pharmaceutical active ingredients in Canada and France. It develops programs in the areas of diabetes, anti-inflammatories, and anti-infectives for therapeutics; and anti-aging and depigmenting agents in cosmeceuticals. The company was formerly known as High Rider Capital Inc. and changed its name to Sirona Biochem Corp. in May 2009. Sirona Biochem Corp. was incorporated in 2006 and is headquartered in Vancouver, Canada.

Corporate Governance

Sirona Biochem Corp.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.